Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for HIVE. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: HIVE is a Strong Sell candidate.
HIVE price ended at $0.073188 on 星期日, after rising 0.93%
On Feb 08, 2026 00:00, the price of HIVE rose by 0.93%, climbing from $0.073601 to $0.073188 with 24h trading volume reaching $2.0M HIVE.
